Transcriptional silencing of antitumor genes via CpG island methylation could be a mechanism mediating prostate cancer (PCa) progression from an androgensensitive (AS) to an androgen-insensitive (AI) state. We have used the methylation-sensitive restriction fingerprinting (MSRF) technique to identify novel CpG-rich sequences that are differentially methylated between the genome of the AS PCa cell line LNCaP and that of an AI subline LNCaP CS generated by maintaining LNCaP in medium with charcoal-stripped (CS) serum for over 30 passages. One such sequence identified was located on a 5 0 CpG island that was found to span part of the promoter, exon 1, and part of intron 1 of the peroxisomal membrane protein 24 kDa (PMP24) gene. Using semiquantitative RT-PCR and bisulfite genomic sequencing, we established an inverse relationship between mRNA expression and methylation of the 5 0 CpG island of PMP24. PMP24 mRNA was absent in LNCaP CS and the androgen receptor-negative PC-3 cell line; both exhibited dense methylation in the said CpG island. In contrast, PMP24 mRNA was expressed in LNCaP and normal prostatic epithelial cells (NPrECs) whose PMP24 5 0 CpG island remained unmethylated. Treatment of LNCaP CS and PC-3 with the demethylating agent 5-aza-2 0 -deoxycytidine (5-AZAdC) reactivated PMP24 mRNA expression. Transient transfection of PMP24 into LNCaP CS and PC-3 cells induced a significant reduction in cell growth and soft-agar colony formation potential, suggesting that PMP24 gene product has antitumor properties. These results demonstrate the utility of MSRF in the identification of novel, differentially methylated DNA sequences in the genome and suggest that hypermethylation-mediated silencing of PMP24 is an epigenetic event involved in PCa progression to androgen independence.
Introduction
Prostate cancer (PCa) is currently detected by routine screening of serum levels of prostate-specific antigen (PSA) in males over 50 years of age (Newling, 1996) . Early-detected tumors are usually confined to the gland and potentially curable with radical prostatectomy and/ or radiation. In cases of locally advanced and metastatic disease, the front-line androgen ablation therapy results in an initial stabilization or regression of the disease in approximately 80% of patients. However, within 12-18 months, almost all tumors become refractory to androgen ablation therapy, and to date effective curative treatments are lacking for these tumors. Therefore, understanding the molecular basis underlying the progression of these cancers to androgen independence has long been an important objective of PCa research.
Tumor initiation and progression have traditionally been viewed as a process involving the stepwise acquisition of multiple genetic alternations such as rearrangements, losses, or duplications of chromosomal regions and mutational activation of oncogenes or inactivation of tumor suppressor genes. However, mounting evidence indicates that 'epigenetic' events, that is heritable changes in DNA modification and chromatin structure without alterations in nucleotide sequence, are equally central to the evolution of cancer (Jones and Laird, 1999; Baylin and Herman, 2000) . In recent years, DNA methylation content, level, and pattern have been shown to be an important epigenetic change commonly associated with tumorigenesis Jones and Takai, 2001; Jaenisch and Bird, 2003) . Compared with their normal counterparts, tumor cells often exhibit global hypomethylation of their genome but focal hypermethylation of CpG-rich, regulatory sequences in genes with antitumor functions (Laird and Jaenisch, 1996) . Such CpG-rich clusters, called CpG islands, have recently been defined more stringently (Takai and Jones, 2002) . Among all the putative CpG islands in the human genome, some are located in the 5 0 end of the gene, including the promoter region, the first exon, the first intron, and sometimes the second exon of the genes. These sequences are often referred to as promoter regulatory CpG islands (Jones and Baylin, 2002) . While generally unmethylated in normal cells, they become abnormally hypermethylated in cancer cells, and these epigenetic alterations are frequently associated with transcriptional silencing of their cognate genes.
Transcriptional silencing of an increasing number of genes in the PCa or in PCa cell lines is now known to be associated with hypermethylation of their 5 0 CpG regulatory sequences. These genes include RARb2 (Nakayama et al., 2001) , ER-a (Lau et al., 2000) , pS2 (Lau et al., 2000) , androgen receptor (Jarrard et al., 1998; Nakayama et al., 2000) , AR-associated-protein 70 (ARA70; Tekur et al., 2001) , g-glutamyltransferase (GMT; el Yaagoubi et al., 1998) , E-cadherin (E-cad; Graff et al., 1995) , P-cad (Jarrard et al., 1997a) , RASSF1A (Kuzmin et al., 2002) , p16 (Jarrard et al., 1997b) , glutathione-S-transferase-Pi (GSTPi; Nelson et al., 1997; Lin et al., 2001; Singal et al., 2001) , p14 ARF (Esteller et al., 2000) , p27
kip1 (Kibel et al., 2001 ), progesterone receptor (Lau et al., 2000) , caveolin-1 and a-subunit of inhibin (Schmitt et al., 2002) , and CD44 (Lou et al., 1999; Verkaik et al., 1999) . The biological roles of these genes are diverse; they are all involved in the regulation of basic homeostatic cell mechanisms such as cell cycle regulation, cell-cell interaction, protection against oxidative damage, or tumor suppression. Collectively, these findings strongly support the hypothesis that this epigenetic mechanism plays a critical role in the genesis and/or progression of PCa.
It is now well recognized that recurrent PCa is a spectrum of diseases that differ in clinical presentation and prognosis (Catalona, 1994; Scher et al., 1995) . It is therefore unlikely that a single model is sufficient to represent all the genetic and/or epigenetic alterations in PCa progression. LNCaP is one of the few human PCa cell lines that have retained androgen receptor (AR) and androgen responsiveness (Taplin and Ho, 2001 ). Androgen-insensitive (AI) sublines have however been derived from LNCaP by maintaining LNCaP in a hormonedepleted (charcoal-stripped) medium for many passages (Robbins et al., 1996; Singh et al., 2003) . One of these sublines, referred to here as LNCaP CS , is AI (Robbins et al., 1996; Singh et al., 2003) and is a suitable model for studying androgen-independent PCa growth.
In this study, we employed a technique known as methylation-sensitive restriction fingerprinting (MSRF) (Huang et al., 1997) for the identification of specific sequences whose methylation status changed from 'unmethylated' or 'hypomethylated' in the androgensensitive (AS) LNCaP cells to 'hypermethylated' in the AI LNCaP CS cells. Among an initial pool of over 50 candidates who exhibited this methylation status change, we selected candidates that are located in the 5 0 regions of known genes. Transcript expression studies were then conducted to identify those sequences whose cognate genes are downregulated or suppressed in LNCaP CS compared with LNCaP. Conjointly, these selection criteria allowed us to identify genes that exhibited both loss of expression and increased methylation in their 5 0 CpG-rich regulatory sequences in LNCaP CS compared with LNCaP. One such sequence identified by MSRF was located to a putative 5 0 CpG island of the peroxisomal membrane protein 24 kDa (PMP24) gene (AL050349; Reguenga et al., 1999) , as predicted by computational analyses. Primer extension analyses confirmed that this CpG island encompasses part of the promoter, exon 1, and part of intron 1 of PMP24. Using semiquantitative RT-PCR and bisulfite genomic sequencing, we established an inverse relationship between PMP24 mRNA expression and hypermethylation of the 5 0 CpG island of the gene. Treatment of LNCaP CS with the demethylating agent 5-aza-2 0 -deoxycytidine (5-AZAdC) reactivated PMP24 mRNA expression. Transient transfection experiments further suggest that PMP24 exerts antitumor action in LNCaP CS , but not in LNCaP cells. Collectively, our results demonstrate that MSRF is useful in screening for altered methylation patterns among different cellular genomes and in the isolation/identification of specific sequences contributing to these changes. They further indicate that hypermethylation-mediated silencing of PMP24 may take part in the progression of PCa to androgen-independency.
Results
Identification of a CpG-rich sequence located in the 5 0 region of PMP24 that exhibits differential methylation status among LNCaP, LNCaP CS , and other AI PCa cell lines
To identify novel CpG-rich DNA sequences that are differentially methylated between the AS LNCaP and AI LNCaP CS , we performed comparative MSRF using genomic DNA isolated from LNCaP and LNCaP CS ( Figure 1 ). In addition, we have exposed LNCaP CS cells to HI-FBS for 3-4 passages in order to determine whether steroid depletion-induced methylation changes in specific DNA sequences could be easily reversed by short-term exposure to full serum. As additional controls, we included genomic DNA from two other AI PCa cell lines, PC-3 and DU145, for comparison. Genomic DNA isolated from different cell lines was subjected to MseI restriction digestion. Since the restriction site of MseI is TTAA, which is rare in CGrich regions, cellular DNA was digested into small fragments while most of the CG-rich regions remained intact. The MseI-digested DNA from each cell line was then subjected to digestion with BstUI, a methylationsensitive restriction enzyme. Short DNA sequences with methylated BstUI sites were left uncut and amplified by PCR with a pair of arbitrary primers, while sequences with unmethylated BstUI sites were digested and yielded no PCR products. The PCR products were sizefractionated in high-resolution polyacrylamide gels along with PCR products obtained from MseI-digested (single enzyme-digestion) genomic DNA serving as a PCR positive control. Figure 1a is a schematic illustration showing the expected results when a CpG-rich sequence in AI cell lines (LNCaP CS , PC-3, and DU145) is methylated but unchanged, not methylated, hypermethylated, or hypomethylated, compared with status in the AS LNCaP cells. In a section of a 'real' autoradiograph (Figure 1b) , shown as examples, there are two DNA sequences that are differentially hypo-(candidate 1) or hyper-(candidate 2) methylated at their BstUI sites in LNCaP CS (lanes 1 and 2) or the other AI cell lines (PC-3 or DU145) compared with LNCaP (lanes 5 and 6). The altered methylation patterns in these sequences are permanent and not easily reversible by short-term exposure of LNCaP CS cells to full serum (lanes 3 and 4).
A total of 12 PCRs were performed with different permutations of primer pairs selected from a set of six arbitrary primers in order to 'screen' a significant portion of the genome for differentially methylated sequences between LNCaP and the AI cell lines. Once confirmed with multiple rounds of PCR and gel electrophoresis, the bands of interest (those representing hypermethylation in AI cell lines compared with LNCaP) were isolated from the gel, DNA eluted, reamplified by PCR with the same pair of arbitrary primers used in the original PCR, cloned, and sequenced. BLAST and other sequence-searching programs were used to determine the composition of the sequences.
From Among the short list of priority candidates, we identified a 125-bp DNA fragment that was judged by MSRF analyses to be hypermethylated in LNCaP CS and PC-3 compared with LNCaP ( Figure 1b , candidate 2). BLAST search indicated that the sequence composition of this fragment exactly matched intron 1 of a previously known gene, the PMP24 gene (AL050349) (Figure 2a ). Computational sequence analyses showed that the identified intron 1 is part of a putative 625-bp CpG island in the 5 0 end region of PMP24 with a GC content of 68% and an observed/expected CpG ratio of 0.79.
To characterize the composition of the putative CpG island of PMP24, primer extension analysis was performed using total RNA isolated from primary culture of NPrEC cells, which express PMP24 mRNA, to map the transcription start site (TSS) of PMP24 mRNA. One antisense extension primer, PE1, was designed complementary to position 16-39 relative to the translational start site. Another primer, PE2, 54 bp upstream of PE1, stretching from À40 toÀ16 nt, was also used to confirm the specificity of the primer extension products. A single extension fragment was obtained by PE1 primer in the presence of total RNA from NPrEC ( Figure 2b , lane þ ), which was absent in the sample without RNA (Figure 2b , lane À). The primer extension reaction using PE2 produced a fragment exactly 54 bp smaller than the PE1 extension product, thus confirming the specificity of the primer extension products. According to the sequencing reaction using 32 P-labeled PE1 primer run next to the extension products on the gel, the TSS was therefore mapped to 67 bp upstream from the ATG start site, indicating that the putative CpG island of PMP24 gene actually encompasses part of the promoter, exon 1, and part of intron 1 of the gene as shown in Figure 2a . (2) whether the change could be easily reversed by exposing LNCaP CS to full serum for 3-4 passages ( Figure 3a , lane 2). PMP24 mRNA was absent from LNCaP CS and PC-3 cell lines but was expressed in LNCaP, DU145, primary cultures of NPrEC (Figure 3b ), and immortalized NPrEC (data not shown). In parallel, we had quantified transcript levels of two other known PMP genes, PMP22 and PMP70, in order to establish that the loss of PMP24 expression is gene-specific. Messenger RNA levels of PMP22 and PMP70 in all PCa cell lines examined were comparable ( Figure 3a) .
We then determined whether silencing of PMP24 transcription is specific to certain PCa cell lines including LNCaP CS ( Figure 3b ). Using high cycle number RT-PCR, we confirmed the absence of PMP24 mRNA in LNCaP CS and PC-3 cells, and showed the presence of this transcript in immortalized normal human ovarian surface epithelial (HOSE) cell lines, ovarian cancer (OVCA) cell lines, the nonmalignant breast epithelial cell line MCF-10A, the malignant The underscored segment represents the putative CpG island encompassing part of promoter, exon 1, and part of intron 1, with a GC content of 68% and an observed/expected CpG ratio of 0.79 predicted by computational program using the criteria: GC content 460% and an observed/expected CpG ratio 40.6 for a putative CpG island. The double-lined region is the fragment amplified by nested PCR after bisulfite modification, cloned, and sequenced to obtain 8-10 clones from each sample (see Figure 4) . (b) TSS was mapped by primer extension analysis. Single band was obtained with either primer PE1 or PE2, in the presence (lane marked as þ ) or absence (lane marked as À) of total RNA obtained from primary culture of NPrEC, which expresses PMP24 mRNA. These two bands were exactly 54 bp apart according to the sequencing reaction run next to them, matching the position where PE1 and PE2 are designed 
Demethylation reactivated PMP24 transcript expression in LNCaP CS and PC-3 cells
Both LNCaP CS and PC-3 showed no detectable or only trace amounts of PMP24 mRNA expression. After 8-day treatment of LNCaP CS and PC-3 with 0.5 or 0.75 mM 5-AZAdC, PMP24 mRNA was re-expressed in these two cell lines (Figure 3c ). On the contrary, 5-AZAdC treatment did not vary the level of PMP24 mRNA expression in LNCaP, which already expressed PMP24 mRNA prior to the treatment (data not shown).
Characterization of methylation status of the putative CpG island of PMP24 in LNCaP and AI PCa cell lines MSRF results only revealed the methylation status of the BstUI sites within the original arbitrary-primed PCR product, which, in the case of PMP24, aligned to a region in its intron 1. However, the putative 5 0 CpG island of PMP24 gene encompasses part of the promoter, exon 1, and intron 1. To reveal the methylation status of the other CpG dinucleotides in this CpG island, we utilized the bisulfite genomic sequencing technique (Frommer et al., 1992; Clark et al., 1994) to fully characterize this region. Bisulfite treatment of DNA specifically converts unmethylated cytosine residues, but not 5-methylcytosine (5 mC), to uracil by deamination (Hayatsu et al., 1970; Wang et al., 1980) . When bisulfite-modified DNA is subjected to PCR, uracil residues are amplified as thymine and unmodified 5 mCs as cytosines. Two pairs of primers were specially designed complementary only to the completely converted DNA to perform nested-PCR to amplify most of the putative CpG island (Figure 2a ) after bisulfite modification of genomic DNA. The amplified products were then cloned, and 8-10 clones were sequenced to reveal the methylation status of 43 CpG dinucleotides in the CpG island of PMP24 in each genomic sample (Figure 4) .
Bisulfite genomic sequencing analyses revealed the methylation status of all 43 CpG dinucleotides in a 573-bp fragment of the putative 5 0 CpG island of PMP24 in primary NPrEC, LNCaP, LNCaP CS , PC-3, and DU145 (Figure 4) . Our data showed that almost all 43 CpG dinucleotides in the CpG island of PMP24 were methylated among the clones derived from DNA obtained from PC-3 and LNCaP CS cell lines. In contrast, the 43 CpG sites in the 5 0 CpG island of PMP24 in primary NPrECs (Figure 4 , top panel) and normal prostate tissues (unpublished data; not shown) were mostly unmethylated, with a few sporadic 5 mCs in some of the clones. Interestingly, clones derived from DNA of LNCaP cells exhibited great heterogeneity; the CpGs in some of the clones were heavily methylated while in others were sparsely methylated. There was also a trend of decreasing methylation frequency towards the 3 0 end of the CpG island. Similarly, PMP24 5 0 CpG island in DU145 also exhibited heavy but incomplete methylation. Combined with the transcript expression studies presented above, these data established an inverse relationship between the extent of methylation in this CpG island and levels of gene transcription detected in the various cell lines.
Ectopic expression of PMP24 in LNCaP
CS and PC-3 inhibited tumor cell growth and soft-agar colony formation potential
To elucidate the functional role of PMP24 in PCa cells, we transiently transfected a PMP24 expression vector Hypermethylation-mediated silencing of PMP24 in LNCaP M-C Wu and S-M Ho into LNCaP CS and PC-3 cells. In a 4-day culture experiment, forced expression of PMP24 in both cell lines resulted in modest, but significant, decreases in cell number (27 and 36%, respectively; Figure 5 ) compared with controls transfected with the empty vector. Furthermore, transient transfection of LNCaP CS and PC-3 cells with PMP24 expression vector also diminished soft-agar colony formation by 24 and 32%, respectively, compared with the cells transfected with empty vector.
Discussion
Disruption of the normal methylation pattern is a common event in tumorigenesis Jones and Takai, 2001 ). Cancer cells showed distinct methylation changes that vary considerably between different tumors, suggesting different degrees of influence exerted by methylation on the transformation process (Liang et al., 1998) . For example, alterations in genomic methylation pattern are quite prevalent in neoplasms of the colon and the bladder. In prostate carcinogenesis, we are just beginning to recognize the influence exerted by DNA methylation on the development and progression of the disease. It is apparent from the current body of knowledge that hypermethylationmediated silencing of tumor suppressor genes and other key cellular regulatory genes is a major epigenetic change associated with oncogenesis in this organ. As exemplified in the current study, progression of PCa from an AS state to an AI state may involve DNA methylation-medieated silencing of specific regulatory genes that could be identified, in an unbiased manner, using MSRF (Huang et al., 1997) . The current study is first to apply this technique to identify genes that may be involved in PCa progression. PMP24, previously not known to be associated with PCa or other cancers, was identified for the first time as a gene regulated by DNA methylation and further shown to exhibit putative antitumor action.
MSRF was first described by Huang et al. (1997) . Other similar techniques such as methylation-sensitive arbitrarily primed PCR (MS AP-PCR) (Gonzalgo et al., 1997) and methylated CpG island amplification (MCA) (Toyota et al., 1999) were developed about the same time in the late 1990s. Subsequent modifications to these techniques have recently been reviewed by Davies (2002) and Liang et al. (2002) . These methodologies hold the promise of providing a rapid and efficient way to screen for changes in methylation patterns in genomic DNA and to isolate specific sequences associated with these changes, in a nonselective manner. Many attempts has been made but only modest success has been achieved in identifying specific genes whose 5 0 CpG sequences undergo methylation changes during tumorigenesis. Using MSRF, Huang et al. (1997) identified two hypermethylation-containing fragments, HBC-1 (for 'hypermethylation in breast cancer') and HBC-2, from DNA isolated from normal and malignant breast tissues. Unfortunately, nucleotide sequence analysis did not match HBC-1 to any known sequences in the GenBank database, whereas the sequence of HBC-2 matched the upstream region of an antisense WT1 (Wilms' tumor suppressor gene) promoter. Kohno et al. (1998) used a similar technique, MS AP-PCR, to analyse genomic DNA from normal lung tissues and non-smallcell lung carcinoma cell lines and identified three DNA fragments containing CpG-rich sequences that were mapped to chromosomes 4q34, 10q26, and 17p13.1-p13.2, respectively; these chromosomal regions were shown to be hypermethylated in a subset of primary lung tumors in vivo. However, these CpG-rich fragments have not yet been linked to any known gene. Liang et al. (2000) used MS AP-PCR and identified a hypermethylated DNA fragment in a human colon tumor cell line. This fragment matched part of a human expressed sequence tag (EST) in GenBank, and this unknown gene (TPEF) encodes a transmembrane protein containing EGF and follistatin domains. The gene exhibits frequent loss of heterozygosity in various tumors.
False positives are a major problem, resulting in the low yield of MSRF and similar techniques (Davies, 2002; Liang et al., 2002) . In addition to the possibility of incomplete restriction digestion, this problem is compounded by the heterogeneity of tumor tissues that commonly comprise mixtures of benign and cancerous tissues expressing varying levels of the differentially methylated genes. Therefore, in this study, we have chosen to use AS and AI LNCaP cell lines as a model to study the methylation status changes during the progression of PCa from an AS to an AI state. In addition, we included other two AI cell lines, PC-3 and DU145, in the MSRF screen. The candidates we selected were those that exhibited hypermethylation in the LNCaP CS subline as well as in one or both AI PCa cell lines. Another reason why MSRF may have low yield is the many CG-rich sequences in the genome whose role in gene regulation is still unclear. For example, the presence of redundant CG-rich elements such as LINE and Alu could be identified by this screening method. Additionally, sequences located downstream of the promoter/5 0 regions of genes are often identified (Liang et al., 1998; Salem et al., 2000) , but their role in regulation of gene expression has yet to be established. For these reasons, among the initial pool of 50 candidate sequences, we focused on those that could be localized to the promoter/5 0 end of the known genes. Since the cognate genes were known, we were able to determine immediately whether significant downregulation or loss of expression of the cognate genes occurred in the AI PCa cell lines compared with LNCaP. These combined strategies of carefully selecting the model system and filtering the candidates have helped us to identify genes relevant to this stage of PCa progression.
A CpG-rich fragment, which was unmethylated in the AS LNCaP but methylated in AI LNCaP CS as well as in PC-3 cells, was identified and matched 100% to a region in intron 1 of PMP24. This region was further identified as part of a 625-bp putative CpG island in the 5 0 region of the gene by computational analyses of gene sequence. This putative CpG island spans part of the promoter, exon 1, and part of intron 1. Using primer extension analyses, we were able to confirm the predictions from computational analyses. The GC content in this CpGrich sequence was found to be 68%, with an observed/ expected CpG ratio of 0.79. Loss of PMP24 expression was clearly associated with close to complete methylation of this CpG-rich sequence in LNCaP CS and PC-3 cells. Together, these data indicated that this CpG-rich fragment fulfills the criteria for a bona fide CpG island (Gardiner-Garden and Frommer, 1987; Takai and Jones, 2002) . Reactivation of transcription of PMP24 in LNCaP CS and PC-3 cells by treatment with the demethylating agent 5-AZAdC is in accordance with the notion that PMP24 is silenced by hypermethylation. However, more direct evidence is needed to demonstrate definitively a causal relationship between PMP24 transcriptional silencing and hypermethylation of this CpG island. For example, it is necessary to show that the putative CpG island possesses promoter activity towards PMP24 transactivation, and hypermethylation of this region abolishes its promoter activity. Such investigations are currently ongoing.
Human PMP24, located in chromosome 20q11.21-13.13, was first cloned after its rat homolog protein was copurified with the other two major peroxisomal membrane components PMP70 and PMP22 (Reguenga et al., 1999) . The gene is highly conserved among different species, with two putative membrane-spanning domains in the conserved region. The PMP24 protein showed no homology to any existing protein motif, and its function remains unknown. Peroxisomes are small (0.5-1.5 mm) multipurpose organelles comprising a single membrane surrounding a dense matrix of enzymes. Peroxisomal enzymes metabolize a broad spectrum of substrates, including long-chain fatty acids, sterols, cholesterol, antibiotics, oxygen-free radicals, and many other metabolites (Masters and Crane, 1998) . Various endogenous and exogenous bioactive molecules are oxidized by oxidases in the peroxisomes, thus generating large quantities of hydrogen peroxide, which is readily rendered harmless by the high levels of catalase in these organelles. Unlike mitochondria, peroxisomes do not possess their own genome, and all proteins are encoded by nuclear genes, synthesized on free cytosolic ribosomes, and imported post-translationally into the organelle (Johnson and Olsen, 2001 ). The peroxisome membrane serves several important functions. First, it regulates import of proteins from the cytosol into the organelle. Second, it keeps the metabolically active enzymes and potentially harmful by-products inside the organelle. Last, members of the peroxisome membrane are known to be involved in the biogenesis of peroxisomes. PMPs are broadly classified into the Type I proteins (e.g. Pex2p, Pex3p, Pex15p, and Pex16p) that are believed to play a role in peroxisome biogenesis and the Type II proteins (e.g. PMP22, PMP34, PMP47, and PMP70) that are not involved in the process (Bryant and Wilson, 1995; Eckert and Erdmann, 2003) . Peroxisomes divide by budding from pre-existing peroxisomes (Marshall, 1995) , and impairment of their biogenesis has apparently been linked to tumor progression. Although Type II PMPs are not involved in peroxisome biogenesis, post-transcriptional-or translational reduction in PMP22 and PMP70 protein expression has been shown to be associated with colon carcinogenesis (Lauer et al., 1999) . Our finding that forced expression of PMP24 in two PCa cell lines inhibited cell growth and soft-agar formation suggests that PMP24 has antitumor function. However, the biological roles of PMP24 in peroxisome regulation and carcinogenesis remain poorly understood and are currently under investigation. Worth mentioning is the proximity of this gene to chromosome 20q13 (HPC20), which has been reported to be linked to a PCa susceptibility region. Fine mapping revealed positive linkage scores spanning from 20pter to 20q11 in subsets of hereditary PCa families (Zheng et al., 2001) . Localization of PMP24 at 20q11.21-13.13 raises the possibility that complete loss of expression could be caused by a second 'hit' caused by methylation-mediated silencing of the gene in some PCa patients.
To our best knowledge, we are the first to report successful application of MSRF in the identification of a methylation-regulating gene of known identity. The identified gene PMP24 encodes a 24-KDa peroxisomal membrane protein and contains a bona fide CpG island. Hypermethylation of this CpG island in the 5 0 region of PMP24 is associated with transcriptional silencing of the gene in PCa cell lines, while forced expression of PMP24 appears to inhibit growth in specific AI cell lines. Taken together, these results suggest that putative antitumor genes can be identified and isolated from PCa by virtue of their altered methylation patterns using methods such as MSRF.
Materials and methods

Cell culture and 5-AZAdC treatment
All PCa cell lines except LNCaP CS were purchased from ATCC (American Type Culture Collection, Manassas, VA, USA). All culture medium contained 1 mM sodium pyruvate, 0.1 M nonessential amino acids, 100 U/ml penicillin, 100 mg/ml streptomycin, 0.05 mM b-mercaptoethanol (Gibco BRL, Carlsbad, CA, USA), and 1% insulin-transferrin-selenium (BD Biosciences, Bedford, MA, USA). PC-3 and DU145 cells were maintained in Dulbecco's minimum essential medium/F-12 (DMEM/F-12) supplemented with 5% charcoal-stripped (CS, steroid-depleted), heat-inactivated fetal bovine serum (HI-FBS) (Sigma, St Louis, MO, USA). LNCaP, an AS human PCa cell line, was grown in RPMI-1640 medium with 25 mM HEPES, 2 mM L-glutamine plus 10% HI-FBS. LNCaP CS was a generous gift from Dr Brain Liu (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA). It is an AI subline derived from LNCaP by being maintained in RPMI-1640 medium with 10% CS-FBS instead of 10% HI-FBS for over 30 passages. All cell cultures were incubated at 371C in a 5% CO 2 humidified atmosphere. For 5-AZAdC (Sigma) treatment, LNCaP CS and PC-3 were seeded at a density of 10 4 cells/ml medium in 25-cm 2 culture flasks, and allowed to attach for 24 h before the treatment. Cells were subjected to a total of 8 days' treatment during which the medium was changed every 4 days and 5-AZAdC was added in aqueous solution at a final concentration of 0.5 or 0.75 mM.
The primary culture of normal prostate epithelial cells (NPrECs) was obtained from Clonetics-BioWhittaker, Inc. (Walkersville, MD, USA); cells were immortalized in our lab by the addition of a retroviral vector expressing HPV-E6/E7 open reading frames (ORFs) as described previously (Tsao et al., 1995) . This NPrEC cell line was grown on the recommended PrEGM medium supplied by Clonetics-BioWhittaker, Inc. Protein markers in these cells were characterized by immunocytochemistry as described by Mobley et al. (2003) .
All the immortalized normal (HOSEs) and cancerous (OVCAs) human ovarian surface epithelial cells were maintained as described by Syed et al. (2001) . TSUPr1, a bladder cancer cell line, was maintained as previously described (Tekur et al., 2001) . The breast cancer cell line MCF-7 was purchased from ATCC. An immortalized normal breast epithelial cell line, MCF10A, was a generous gift from Dr Jinquiang Chen (Johns Hopkins University, Baltimore, MD, USA).
DNA extraction and MSRF
Genomic DNA was extracted from cells with the DNeasy s Tissue Kit (QIAGEN, Valencia, CA, USA) and quantified by spectrophotometer. MSRF was performed as originally described with some modification (Huang et al., 1997) . In brief, 1 mg genomic DNA was digested with MseI alone or double-digested with BstUI and MseI following the conditions recommended by the supplier (New England Biolabs, NEB, Beverly, MA, USA). Digested DNA (20-100 ng) was used in each 20-ml PCR reaction containing 2 mM MgCl 2 , 200 mM dNTP, 5% (v/v) DMSO, 1 U of buffered AmpliTaq Gold DNA polymerase (Perkin-Elmer, Foster City, CA, USA), and 2 mCi [a-32 P]dCTP (3000 Ci/mmol; NEN, Boston, MA, USA). The genomes were analysed by PCRs with various permuations of paired arbitrary primers chosen from the following: Bs1, 5 0 -AGCGGCCGCG; Bs11, 5 0 -GAGAGGCGCG; Bs12, 5 0 -GCCCCCGCGA; Bs13, 5 0 -CGGGGCGCGA; PCG03, CTCCCTCTCG; PCG04, 5 0 -TCCTTCCTCG. PCR was performed under the conditions as previously described (Huang et al., 1997) , and the products were separated on 4.5% nondenaturing polyacrylamide gels that were dried and exposed to Kodak X-OMAT AR film (Kodak, New Haven, CT, USA) to visualize the labeled PCR products as bands on the radiograph. Candidate bands displaying the appropriate differential methylation status among 'control' and 'comparative' cell lines were cut, reamplified, and cloned directly into pGEM-T Easy vector (Promega, Madison, WI, USA) for sequencing. The resulting nucleotide sequences were compared to GenBank using the BLAST program.
RNA isolation and RT-PCR
Total cellular RNA was isolated from various cell lines with Tri-Reagent (Sigma) according to the protocol provided by the manufacturer. RNA was subsequently subjected to DNase treatment to ensure its purity. Total RNA (up to 20 mg) was incubated at 371C for 30 min with 2 U buffered RQ1 RNasefree DNase (Promega), 100 U RNase inhibitor (Perkin-Elmer), and 5 mM DTT (Sigma) in a 100-ml final volume. A standard phenol/chloroform extraction was then performed, followed by precipitation for 1 h at À201C with 2.5 vol of 100% ethanol and 0.1 vol of 3 M sodium acetate. The RNA pellet was retrieved by centrifugation at 10 000 g for 15 min, washed twice with 70% ethanol, and finally dissolved in diethylpyrocarbonate (DEPC) water. Multiple routine examinations were taken to carefully measure the quantity and assess the quality of RNA samples as previously described (Syed et al., 2001) . Total cellular RNA (1 mg) was reverse transcribed with the GeneAmp RNA PCR kit (Perkin-Elmer), and 2 ml out of the 60 ml resulting cDNA was used in each PCR. Intronspanning primers were designed with the Primer3 output program (http://www.genome.wi.mit.edu/cig-bin/primer/primer3.cgi, Whitehead Institute, Cambridge, MA, USA). For amplification of PMP24 from cDNA, the forward primer was 5 0 -ATCAACAGCCAGATCAACATGTAC-3 0 and the reverse primer was 5 0 -GCCAAATCTTGAGCCACAGC-3 0 (MWG Biotech, High Point, NC, USA). In parallel, mRNA levels of two other peroxisomal membrane protein genes, PMP22 and PMP70 (Lauer et al. 1999; Reguenga et al. 1999) , were analysed. The forward primer sequence for PMP22 (AF250136) amplification was 5 0 -GGT GGG CCT CTG AGA TAT GC-3 0 and the reverse primer was 5 0 -TGA TGA GGA AGA ACA ACA TGA GG-3 0 . For human PMP70 (XM_010507) amplification, the sense primer was 5 0 -GCT TAA ACT GTG CTT CCG AGT AAG G-3 0 and the antisense primer was 5 0 -GGA ATA GCC CAG AAA CAA CCA AG-3 0 . Hot-start PCR was performed by heat-activating AmpliTaq Gold DNA polymerase (Perkin-Elmer) at 951C for 10 min. Optimized cycling condition was 36 cycles (for PMP24) or 30 cycles (for PMP22 and PMP70) of denaturing (941C for 30 s), annealing (561C for 30 s) and extension (721C for 60 s), followed by a 10-min final extension. Amplification of the correct sequences was verified by direct DNA sequencing of PCR product at the Nucleic Acid Facility of University of Massachusetts Medical School. Human 18S ribosomal RNA was amplified from cDNA as a loading control as previously described (Tekur et al., 2001) .
Mapping of the transcriptional start site
Two antisense primers, PE1, 5 0 -GACTACGAGCA-GATCCCTTAGCTG-3 0 and PE2, 5 0 -CAGGGTCGGGGT-TAGGAACTGTAAG-3 0 , were designed complementary to position 16-39 and À40 toÀ16 relative to the translational start site, respectively. To label the primers, 10 pmol of each primer was incubated with 30 mCi [g-32 P]ATP (3000 Ci/mmol; Hypermethylation-mediated silencing of PMP24 in LNCaP M-C Wu and S-M Ho NEN) and 20 U T4 Polynucleotide kinase (PNK, NEB) in 1 Â T4 PNK buffer in a total volume of 10 ml at 371C for 30 min followed by 2 min of inactivation at 901C. The labeled mixture was diluted to a final concentration of 100 fmol/ml by adding 90 ml of DEPC water, and 1 ml labeled primer was used in each extention reaction. In a 10-ml reaction mixture, 15 mg of total RNA extracted from primary NPrEC, which expresses PMP24 mRNA, was annealed with 32 P-labeled PE1 or PE2 in 1 Â first strand buffer (50 mmol/ml Tris-HCl; pH 8.3, 75 mmol/ml KCl, 3 mmol/ml MgCl 2 ) at 601C for 20 min followed by 10 min at room temperature. The annealed mixture was mixed with 10 ml of reaction buffer (50 mmol/ml Tris-HCl; pH 8.3, 75 mmol/l KCl, 3 mmol/l MgCl 2 , 50 mmol/l dithiothreitol (DTT), 1 mmol/l dNTPs) and 200 U of SuperScript II RNase H À reverse transcriptase (Invitrogen, Carlsbad, CA, USA), and incubated at 471C for 60 min. The reaction was stopped by the addition of 20 ml loading buffer. A total of 10 ml of the samples was resolved by 6% denaturing polyacrylamide gel electrophoresis. The same reactions without total RNA were carried out in parallel as negative controls. As a size standard, genomic DNA from NPrEC was amplified with PE1 and PMP24seqF3
(5 0 -CTCCCTGTATCATCACCTGTCG-3 0 , À410 to À389 nt). A sequencing reaction was carried out for PCR product using 32 P-labeled PE1 primer and loaded next to the primer extension product. The gel was then dried and visualized with a phosphoimager Storm 840 (AmershamPharmacia, Piscataway, NJ, USA).
Bisulfite sequencing
Genomic DNA (1 mg) from various cell lines as well as two normal prostate tissue samples was modified with sodium bisulfite using the CpGemonet DNA Modification Kit (Intergen, Phurcase, NY, USA) following the manufacturer's instruction. Modified DNA was finally dissolved in 25 ml TE (10 mM Tris/0.1 mM EDTA, pH 7.5) and used immediately or stored at -801C until use. Modified DNA (2 ml) was used in nested PCR for bisulfite sequencing. Primers for amplifying completely converted DNA were designed with Primer3 applying the criteria described by Grunau et al. (2001) . First, PCR was performed using forward primer PMP24BS-F1 (5 0 -TGAATTTAATATGGTTTAAGGGAAAGTGTT-3 0 ) and reverse primer PMP24BS-R1 (5 0 -CACAAAAAAATAAAA-TAAACTAAACCCAAA-3 0 ). Primers for nested PCR were PMP24BS-F2 (5 0 -GAGTTTATTGTGATTGGTTATAAG-TTTTTT-3 0 ), forward, and PMP24BS-R2 (5 0 -CAAAACAAA-AAAACCAAACTACAAAAATTA-3 0 ), reverse. Both PCRs were performed under the condition of initial hot-start at 951C for 10 min, 40 cycles of denaturing (941C for 30 s), annealing (501C for 30 s) and extension (721C for 60 s), followed by a 10-min final extension. PCR product was extracted from agarose gel with QIAquick s gel extraction kit (QIAGEN) and cloned into pGEM-T Easy vector (Promega); 8-10 clones were picked for each cell line for sequencing.
Plasmids, transient transfection, and soft-agar assay
The full-length PMP24 cDNA was amplified by PCR using forward primer: 5 0 -GAA TTC AGC CCG CAC TAT GGC AG-3 0 and reverse primer: 5 0 -AAG CTT GCA TTA ATT GGA GGG ACG G-3 0 . The PMP24 expression plasmid (pTriEX-PMP24) was constructed by cloning the full-length cDNA into pTriEX-1 vector (Novagen, Madison, WI, USA). The PMP24 ORF was confirmed by sequencing in both directions. Transient transfection of LNCaP, LNCaP CS , and PC-3 cells was performed with LipofectAMINE PLUS Reagent (Life Technologies, Inc., Rockville, MD, USA) according to the manufacturer's instruction. For monitoring transfection efficiency in these three cell lines, 1 Â 10 À5 cells were transfected with 1 mg pCMV-b Galactosidase control vector (Progema, Madison, WI, USA) in a six-well plate. Cells transfected with pCMV-b galactosidase control vector and expressed b-galactosidase were visualized by microscopy. In brief, after transfection, the cells were fixed in glutaraldehyde solution for 15 min, extensively washed in PBS 1 Â buffer, and incubated with 0.2% X-Gal solution in PBS containing 2 mM MgCl 2 , 5 mM K 4 Fe(CN) 6 Á 3H 2 O, and 5 mM K 3 Fe(CN) 6 . The cells that appeared blue after fixation and incubation with XGal were counted to estimate efficiency of transformation. After establishing the transfection efficiencies, LNCaP, LNCaP CS , and PC-3 cells were transfected with 1 mg of either the PMP24-containing vector (pTriEX-PMP24) or the empty vector (as control). Cells (1 Â 10 5 ) were plated in six-well plates and allowed for attachment in serum-supplemented medium for 24 h. Approximately 60-80% confluent cells were transfected in serum-free medium for 3 h at 371C and incubated with complete medium for 48 h. The cells were harvested by scraping, washed with PBS, pelleted, and counted on a hemocytometer. The same transient transfection experiment was repeated in LNCaP CS and PC-3 cells. At 24 h posttransfection, cells from each culture were seeded at low density (500 cells/plate (100 mm), four plates per sample) in 0.3% agar in complete medium on top of an underlayer of 0.6% Noble agar with complete medium (Salmon et al., 1978) . Plates were incubated for up to 4 weeks. The numbers of colonies growing on soft-agar plates were scored to establish the soft-agar colony formation frequency, expressed as number of colonies/ 100 cells plated.
